Published in J Natl Cancer Inst on December 18, 2002
Clinical trials and medical care: defining the therapeutic misconception. PLoS Med (2007) 3.77
Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg (2005) 2.00
Does random treatment assignment cause harm to research participants? PLoS Med (2006) 1.39
Clinicians' attitudes towards clinical trials of cancer therapy. Br J Cancer (2011) 1.17
Ethical issues at the interface of clinical care and research practice in pediatric oncology: a narrative review of parents' and physicians' experiences. BMC Med Ethics (2011) 1.16
Financial considerations in the conduct of multi-centre randomised controlled trials: evidence from a qualitative study. Trials (2006) 1.15
The ethical use of mandatory research biopsies. Nat Rev Clin Oncol (2011) 1.11
Incidental findings of therapeutic misconception in biobank-based research. Genet Med (2012) 1.06
What research ethics should learn from genomics and society research: lessons from the ELSI Congress of 2011. J Law Med Ethics (2012) 0.96
What motivates participation in HIV cure trials? A call for real-time assessment to improve informed consent. J Virus Erad (2015) 0.96
The relevance of empirical research in bioethics. Schizophr Bull (2005) 0.95
Nurse Practitioners' attitudes about cancer clinical trials and willingness to recommend research participation. Contemp Clin Trials (2011) 0.95
Information disclosure in clinical informed consent: "reasonable" patient's perception of norm in high-context communication culture. BMC Med Ethics (2014) 0.91
Clinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death. J Pain Symptom Manage (2013) 0.90
Ethical issues in perinatal mental health research. Curr Opin Psychiatry (2009) 0.88
When is it rational to participate in a clinical trial? A game theory approach incorporating trust, regret and guilt. BMC Med Res Methodol (2012) 0.86
Ethical significance of ethics-related empirical research. J Natl Cancer Inst (2002) 0.85
Therapeutic Misconception in Psychiatry Research: A Systematic Review. Clin Psychopharmacol Neurosci (2016) 0.78
The Effect of Receiving Treatment Within a Clinical Trial Setting on Survival and Quality of Care Perception in Advanced Stage Non-Small Cell Lung Cancer. Am J Clin Oncol (2016) 0.78
Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer. JAMA Oncol (2015) 0.75
Re: Views of American oncologists about the purposes of clinical trials. J Natl Cancer Inst (2003) 0.75
Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol (2004) 7.45
Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2004) 7.02
Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol (2008) 5.61
Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review. Lancet (2004) 4.99
Identifying potential indicators of the quality of end-of-life cancer care from administrative data. J Clin Oncol (2003) 4.50
Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol (2003) 4.24
Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study. BMJ (2014) 3.90
Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions. J Natl Cancer Inst (2012) 3.16
Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol (2002) 3.09
End-of-life discussions, goal attainment, and distress at the end of life: predictors and outcomes of receipt of care consistent with preferences. J Clin Oncol (2010) 2.97
Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA (2010) 2.93
Palliative radiation therapy practice in patients with metastatic non-small-cell lung cancer: a Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) Study. J Clin Oncol (2013) 2.91
Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol (2011) 2.83
HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis. J Clin Oncol (2004) 2.78
Evaluating claims-based indicators of the intensity of end-of-life cancer care. Int J Qual Health Care (2005) 2.75
American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol (2008) 2.69
Physicians' attitudes about multiplex tumor genomic testing. J Clin Oncol (2014) 2.62
Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer. JAMA (2012) 2.56
Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis. J Natl Cancer Inst (2008) 2.56
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer. J Clin Oncol (2012) 2.53
Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis. J Clin Oncol (2005) 2.52
Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730). J Clin Oncol (2005) 2.48
Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study. Radiology (2008) 2.37
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst (2006) 2.34
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol (2006) 2.29
A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the National Comprehensive Cancer Network. Ann Surg (2006) 2.29
Representativeness of participants in the cancer care outcomes research and surveillance consortium relative to the surveillance, epidemiology, and end results program. Med Care (2013) 2.22
Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2010) 2.16
Parents' views of cancer-directed therapy for children with no realistic chance for cure. J Clin Oncol (2008) 2.12
Emergence of sentinel node biopsy in breast cancer as standard-of-care in academic comprehensive cancer centers. J Natl Cancer Inst (2003) 2.11
End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95
Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol (2009) 1.94
Treatment decision making in early-stage breast cancer: should surgeons match patients' desired level of involvement? J Clin Oncol (2002) 1.89
Site of oncologic specialty care for older adolescents in Utah. J Clin Oncol (2007) 1.87
Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles? J Clin Oncol (2010) 1.84
Parent and physician perspectives on quality of care at the end of life in children with cancer. J Clin Oncol (2005) 1.78
Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med (2009) 1.77
Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer (2012) 1.75
Hope and prognostic disclosure. J Clin Oncol (2007) 1.73
Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes. J Natl Cancer Inst (2011) 1.71
Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants. J Natl Cancer Inst (2005) 1.70
Selecting high priority quality measures for breast cancer quality improvement. Med Care (2008) 1.70
Medical oncologists' perceptions of financial incentives in cancer care. J Clin Oncol (2012) 1.69
Communication about prognosis between parents and physicians of children with cancer: parent preferences and the impact of prognostic information. J Clin Oncol (2006) 1.66
High-cost imaging in elderly patients with stage IV cancer. J Natl Cancer Inst (2012) 1.63
Improving the care of children with advanced cancer by using an electronic patient-reported feedback intervention: results from the PediQUEST randomized controlled trial. J Clin Oncol (2014) 1.63
Peer-delivered smoking counseling for childhood cancer survivors increases rate of cessation: the partnership for health study. J Clin Oncol (2005) 1.61
Understanding of prognosis among parents of children with cancer: parental optimism and the parent-physician interaction. J Clin Oncol (2007) 1.56
Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol (2002) 1.55
Quality of health care for children: role of health and chronic illness in inpatient care experiences. Arch Pediatr Adolesc Med (2007) 1.53
Easing of suffering in children with cancer at the end of life: is care changing? J Clin Oncol (2008) 1.52
Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery? Med Care (2009) 1.51
Communication between physicians and older women with localized breast cancer: implications for treatment and patient satisfaction. J Clin Oncol (2002) 1.49
A qualitative study of oncologists' approaches to end-of-life care. J Palliat Med (2008) 1.49
Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol (2005) 1.44
Considerations about hastening death among parents of children who die of cancer. Arch Pediatr Adolesc Med (2010) 1.44
Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness. J Clin Oncol (2003) 1.41
Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol (2006) 1.39
An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population. Health Econ (2003) 1.34
Looking beyond where children die: determinants and effects of planning a child's location of death. J Pain Symptom Manage (2008) 1.33
Do variations in provider discussions explain socioeconomic disparities in postmastectomy breast reconstruction? J Am Coll Surg (2008) 1.31
Receipt of appropriate surgical care for Medicare beneficiaries with cancer. Arch Surg (2011) 1.31
Expectations about the effectiveness of radiation therapy among patients with incurable lung cancer. J Clin Oncol (2013) 1.30
The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer (2010) 1.30
Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol (2007) 1.29
Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active cancer treatment. J Clin Oncol (2009) 1.28
Institutional variation in the surgical treatment of breast cancer: a study of the NCCN. Ann Surg (2011) 1.28
Adopting helical CT screening for lung cancer: potential health consequences during a 15-year period. Cancer (2008) 1.26
Treatment of early stage breast cancer: do surgeons and patients agree regarding whether treatment alternatives were discussed? Breast Cancer Res Treat (2003) 1.26
Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study. Breast Cancer Res (2012) 1.26
Direct-to-consumer advertising in oncology: a content analysis of print media. J Clin Oncol (2007) 1.25
Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. Int J Radiat Oncol Biol Phys (2006) 1.25
Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts. Med Care (2014) 1.24
Incremental treatment costs in national cancer institute-sponsored clinical trials. JAMA (2003) 1.22
Hospice care and survival among elderly patients with lung cancer. J Palliat Med (2011) 1.22
Attitudes of patients with cancer about personalized medicine and somatic genetic testing. J Oncol Pract (2012) 1.21
Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study. J Clin Oncol (2004) 1.20
The impact of breast reconstruction on the delivery of chemotherapy. Cancer (2010) 1.20
Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ. J Clin Oncol (2007) 1.18
Underuse of hospice care by Medicaid-insured patients with stage IV lung cancer in New York and California. J Clin Oncol (2013) 1.16
The effect of age on delay in diagnosis and stage of breast cancer. Oncologist (2012) 1.15
Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network. J Clin Oncol (2008) 1.15
Altruism among participants in cancer clinical trials. Clin Trials (2011) 1.15
Regional variation in spending and survival for older adults with advanced cancer. J Natl Cancer Inst (2013) 1.14
Estimation of mortality rates for disease simulation models using Bayesian evidence synthesis. Med Decis Making (2006) 1.14
When does quality-adjusting life-years matter in cost-effectiveness analysis? Health Econ (2004) 1.14
The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers. J Clin Oncol (2006) 1.13
Long-term follow-up and individual item analysis of quality of life assessments related to laparoscopic-assisted colectomy in the COST trial 93-46-53 (INT 0146). Ann Surg Oncol (2011) 1.09
Optimistic expectations and survival after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2003) 1.08
Quality-of-life-adjusted survival analysis of high-dose adjuvant interferon alpha-2b for high-risk melanoma patients using intergroup clinical trial data. J Clin Oncol (2002) 1.07
Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study. Ann Intern Med (2014) 1.05
Chapter 9: The MGH-HMS lung cancer policy model: tobacco control versus screening. Risk Anal (2012) 1.05
Enrollment of patients with lung and colorectal cancers onto clinical trials. J Oncol Pract (2013) 1.05
Employment among survivors of lung cancer and colorectal cancer. J Clin Oncol (2010) 1.02
Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate? J Natl Cancer Inst (2013) 1.00
Impact of patient age and comorbidity on surgeon versus oncologist preferences for adjuvant chemotherapy for stage III colon cancer. J Am Coll Surg (2008) 1.00
Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States. Int J Radiat Oncol Biol Phys (2012) 1.00
Unmeasured costs of a child's death: perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost children to cancer. J Clin Oncol (2011) 0.98